Martin-Medina, A. ; Lehmann, M. ; Burgy, O.* ; Hermann, S. ; Baarsma, H.A. ; Wagner, D.E. ; De Santis, M. ; Ciolek, F. ; Hofer, T.P. ; Frankenberger, M. ; Aichler, M. ; Lindner, M.* ; Gesierich, W.* ; Guenther, A.* ; Walch, A.K. ; Coughlan, C.* ; Wolters, P. * ; Lee, J.S.* ; Behr, J. ; Königshoff, M.
     
 
    
        
         Increased extracellular vesicles mediate WNT5A signaling in idiopathic pulmonary fibrosis.
        Increased extracellular vesicles mediate WNT5A signaling in idiopathic pulmonary fibrosis.
     
    
        
    
    
        
        Am. J. Respir. Crit. Care Med. 198, 1527-1538 (2018)
    
    
    
		
		
			
				Rationale: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease characterized by lung epithelial cell injury, increased (myo) fibroblast activation, and extracellular matrix deposition. Extracellular vesicles (EVs) regulate intercellular communication by carrying a variety of signaling mediators, including WNT (wingless/integrated) proteins. The relevance of EVs in pulmonary fibrosis and their potential contribution to disease pathogenesis, however, remain unexplored.Objectives: To characterize EVs and study the role of EV-bound WNT signaling in IPF.Methods: We isolated EVs from BAL fluid (BALF) from experimental lung fibrosis as well as samples from IPF, non-IPF interstitial lung disease (ILD), non-ILD, and healthy volunteers from two independent cohorts. EVs were characterized by transmission electron microscopy, nanoparticle tracking analysis, and Western blotting. Primary human lung fibroblasts (phLFs) were used for EV isolation and analyzed by metabolic activity assays, cell counting, quantitative PCR, and Western blotting upon WNT gain- and loss-of-function studies.Measurements and Main Results: We found increased EVs, particularly exosomes, in BALF from experimental lung fibrosis as well as from patients with IPF. WNT5A was secreted on EVs in lung fibrosis and induced by transforming growth factor-beta in primary human lung fibroblasts. The phLF-derived EVs induced phLF proliferation, which was attenuated by WNT5A silencing and antibody-mediated inhibition and required intact EV structure. Similarly, EVs from IPF BALF induced phLF proliferation, which was mediated by WNT5A.Conclusions: Increased EVs function as carriers for signaling mediators, such as WNT5A, in IPF and thus contribute to disease pathogenesis. Characterization of EV secretion and composition may lead to novel approaches to diagnose and develop treatments for pulmonary fibrosis.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Lung Fibrosis ; Exosomes ; Lung Fibroblasts ; Proliferation ; Wnt5a; Tgf-beta; Exosomes; Pathway; Activation; Mechanisms; Fibroblasts; Expression; Secretion; Repair; Cells
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2018
    
 
    
        Prepublished im Jahr 
        
    
 
    
        HGF-Berichtsjahr
        2018
    
 
    
    
        ISSN (print) / ISBN
        1073-449X
    
 
    
        e-ISSN
        1535-4970
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 198,  
	    Heft: 12,  
	    Seiten: 1527-1538 
	    Artikelnummer: ,  
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            American Thoracic Society
        
 
        
            Verlagsort
            25 Broadway, 18 Fl, New York, Ny 10004 Usa
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30202 - Environmental Health
80000 - German Center for Lung Research
90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
30205 - Bioengineering and Digital Health
    
 
    
        Forschungsfeld(er)
        Lung Research
Helmholtz Diabetes Center
Immune Response and Infection
Enabling and Novel Technologies
    
 
    
        PSP-Element(e)
        G-503100-001
G-501800-311
G-501903-009
G-503100-007
G-501600-001
G-502710-001
G-501600-012
G-500390-001
G-501600-002
G-501600-006
    
 
    
        Förderungen
        
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2018-07-27